+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757



Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757



American Journal of Obstetrics and Gynecology 195(1): 62-71



This study was undertaken to compare utilization of health services and health care costs in a randomized hormone therapy trial. A total of 1823 healthy postmenopausal women aged 50 to 64 years at the time of sampling were allocated to combined continuous hormone therapy or placebo or no treatment. The analysis was based on routinely collected electronic data in the Estonian Health Insurance Fund database during a follow-up period from 2 to 5 years. In the nonblind subtrial, the number of all health care visits was 10% higher and the number of visits to family practitioners 16% higher per person-year in the hormone therapy arm. Per person-year, the number of vaginal sonograms was 14% and the number of electrocardiograms 19% higher in the nonblind hormone therapy arm. Outpatient health care costs and drug expenses were higher in the nonblind hormone therapy arm. In the blind subtrial, the number of gynecologic operations, vaginal sonograms and total health care costs was higher in the hormone therapy arm. Hormone therapy caused additional expenses on health care.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049961363

Download citation: RISBibTeXText

PMID: 16813745

DOI: 10.1016/j.ajog.2005.12.037


Related references

Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757. Bjog 114(5): 548-554, 2007

Who wants to join preventive trials?--Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757. Bmc Medical Research Methodology 5: 12, 2005

Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757. Maturitas 55(2): 162-173, 2006

Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757. Maturitas 52(3-4): 286-295, 2005

The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial. Bmc Research Notes 5: 176, 2013

Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial. Bmc Medical Research Methodology 12: 44, 2012

Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial. Bmc Women's Health 8: 5, 2008

Experiences of a long-term randomized controlled prevention trial in a maiden environment: Estonian Postmenopausal Hormone Therapy trial. Bmc Medical Research Methodology 8: 51, 2008

Variability of bothersome menopausal symptoms over time--a longitudinal analysis using the Estonian postmenopausal hormone therapy trial (EPHT). Bmc Women's Health 12: 44, 2013

Variability of bothersome menopausal symptoms over time -- a longitudinal analysis using the Estonian postmenopausal hormone therapy trial EPHT. BMC Women's Health 12(1), 2012

Effects of hormone replacement therapy on endometrial histology in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA (Journal of the American Medical Association) 275(5): 370-375, 1996

The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. Menopause 17(3): 622-629, 2010

Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: The Postmenopausal Estrogen/Progestins Interventions (PEPI) trial. Journal of Clinical Epidemiology 52(12): 1187-1195, 1999

Coagulation factors, postmenopausal hormone replacement therapy and postmenopausal hormone therapy. 2007

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 275(5): 370-375, 1996